Abstract. To investigate whether vascular risk affects the progression of Alzheimer's disease (AD), 415 AD patients aged 65 years old and over without cerebrovascular diseases were enrolled and administered with a structured interview to assess demography, vascular risk factors, and cognitive and functional status at baseline, and 324 AD patients were followed up annually for 5 years. A mixed random effects regression model was used to identify the association between vascular risk, individual vascular risk factors, and the progression of AD. After adjusting for confounding factors, AD patients with vascular risk had faster cognitive and functional decline rates than the subjects without such risk factors. Individual vascular risk factors including hypertension and diabetes mellitus, transient ischemic attack and cerebrovascular accident during the follow-up were independently associated with the progression of AD. Our findings suggest that vascular risk aggravates the progression of AD and may be involved in the etiologic process of AD. As such, control of vascular risk may slow down the progression of AD.
INTRODUCTION
Alzheimer's disease (AD), characterized by progressive cognition decline, is the most common form of dementia and is the major health issue, along with cerebrovascular diseases (CVD), affecting the increasing elderly population [1] . Vascular risk factors, including diabetes mellitus, atherosclerosis, hypertension, thrombotic episodes, atrial fibrillation, smoking, and obesity, are common comorbidities with the elderly and also contribute to the cognitive decline and development of AD in the elderly [2] . The role of vascular risk factors in the pathogenesis of AD remains unknown. It is important to understand whether vascular diseases are intrinsic to the pathogenesis of AD or only have an additive effect. Recent epidemiological studies have shown that vascular risk factors are related to the increased risk of AD, suggesting the role of vascular risk factors in the development of AD [3] [4] [5] [6] [7] . However, the effect of vascular risk factors on the progression of AD is less studied. It is of highly clinical significance to investigate the association between vascular risk factors and the progression of AD in term of prevention and treatment.
With the aging of the population, China has a huge prevalence of both AD and stroke [8] . Because of the differences in race, economic level, and lifestyles, vascular risk factors and their effects on the progression of AD may differ from that in western countries [9] . So far, there has not been an investigation specifically focused on the association between vascular risk factors and the progression of AD in China. Ad hoc, we conducted a 5-year longitudinal prospective study enrolling a large cohort of 324 patients with AD to investigate the effect of vascular risk factors, as well as new cerebrovascular accident (CVA) occurring during the follow-up, on the progression of AD.
METHODS

Study subjects
Chongqing, the largest municipality directly under the central government in western China, has a population of 35 million, of which ten million live in urban areas. The city of Chongqing is located in the middle of Chongqing, where there is a total population of three million. Subjects were sampled from seven randomly selected communities in the city of Chongqing. Eligibility requirements included subjects: 1) who were 65 years old and over; and 2) who were long-term residents of these communities. Exclusion criteria were: 1) having significant vascular diseases (e.g., having CVD diagnosed by a history of stroke or brain imaging including strategic lesion, multiple lesions, or diffuse white matter lesions [10] ; having a Hachinski score > 4); 2) a concomitant neurological disorder potentially affecting cognitive function (e.g., severe Parkinson's disease); 3) a diagnosis of other type of dementia; 4) being unable to comply with the study assessment; 5) enduring mental illness; 6) alcohol or drug abuse; or 7) moving away or declining to participate.
This study was approved by the Institutional Review Board of the Third Military Medical University, and all subjects and their caregivers provided informed consent.
Baseline screening
The baseline screening of the present study was performed between January 1, 2004 and June 30, 2004. In the seven selected communities, there was a total of 8735 people aged 65 and above, of which 7831 were screened at baseline. The 904 subjects, who were not available at the time of screening (n = 613) or declined to participate (n = 291), did not significantly differ from the participants in age, gender, or occupation. The subjects and their caregivers were interviewed by holding meetings in community centers. For people who were absent at the meeting time, or who were not able to attend due to physical disabilities, our staff went to their home to perform the interview.
The following data were collected: demographic data, smoking and drinking status, medical history, clinical assessment, functional and cognitive status, and depressive symptomatology. These procedures were administered by trained interviewers composed of experienced neurologists, psychiatrists, and senior nurses. The Cohen's K statistic was used to measure the reliability across interviewers. The agreement on data collection was found to be excellent based on the same sample of subjects, with a kappa of 0.92.
(1) Demographic data: These data included age, gender, educational level [lower educational level (illiteracy or primary school) and higher educational level (above secondary school)] and occupation (blue collar or white collar).
(2) Smoking and drinking: Smoking and drinking status were collected from informants. The smoking status was classified as: i) past smokers who had quit smoking for at least 6 months; ii) current smokers; or iii) those who never smoked a cigarette. Drinking status was classified as daily drinking, weekly drinking, monthly drinking, or occasional drinking as defined previously [11] .
(3) Clinical assessment: In the interview, medical history was collected from medical records. The data included prior head trauma and surgery, prior gas poisoning, schizophrenia, hypothyroidism, coronary heart diseases, atrial fibrillation, CVA, transient ischemic attack (TIA), chronic obstructive pulmonary disease, chronic hepatitis, chronic renal insufficiency, hypertension, diabetes mellitus, hypercholesterolemia, Parkinson's disease, and regular use of nonsteroidal antiinflammatory drugs (NSAIDs).
Blood pressure measurement and electrocardiogram were performed on-site,and fasting blood samples were collected to measure hemogram, fasting glucose, thyroxin, creatinine, uric acid, transaminase, total cholesterol, and APOE4. Body mass index was also measured. Subjects with abnormalities, implying potential diseases that were not previously diagnosed, were introduced to Chongqing Daping hospital for further investigation. Diagnosis of diseases including anemia, hypothyroidism, hypertension, diabetes mellitus, hypercholesterolemia, obesity, coronary heart diseases, atrial fibrillation, CVA, TIA, chronic renal insufficiency, and chronic hepatitis were based on International Classification of Diseases, ninth Revision (ICD-9).
(4) Neuropsychological evaluation: Cognitive status was assessed using the Chinese version of the MiniMental Status Examination (MMSE) which was previously validated in the Chinese elderly [9, 12, 13] . Additive scores of MMSE ranged from 0 to 30. The boundary score of MMSE was defined as 17 (illiteracy), 20 ( 6 years of education), and 24 (> 6 years of education). The subjects with cognitive decline after MMSE screening were further administered a battery of neuropsychological tests developed for epidemiological dementia studies to all subjects [9] . This neu-ropsychological battery included: Fuld Object Memory Evaluation for detecting extensive cognitive dysfunction mainly composed of memory [14] , Rapid Verbal Retrieve for detecting the function of semantic memory [15] , Wechsler Adult Intelligence Scale for evaluating immediate memory and function of graphical recognition [16] , Pfeiffer Outpatient Disability Questionnaire for assessing ability of social activities [17] , Hamilton Depression Rating Scale for measuring emotional status [18] , and Hachinski Ischemic Score (HIS) for evaluating significant vascular disease [19] .
The functional ability in basic and instrumental activities was evaluated using modified Activities of Daily Living (ADL) [20] , which contained 20 basic and instrumental activities of daily living. Each activity were rated on a 4 points scale, with 1 point indicating "no limitation", 2 points indicating "does activity by oneself with some difficulties", 3 points indicating "needs help with activity", and 4 points indicating "unable to do activity". Additive score of ADL ranges from 20 to 80, an ADL score of > 20 indicated that the subject had some difficulties in self-care.
(5) Diagnosis of AD: The clinical diagnosis of AD was made by a group of senior neurologists and psychiatrists following the protocol described in our previous studies [9] . In brief, dementia was diagnosed based on criteria modified from the Diagnostic and Statistical Manual of Mental Disorders, 4th edition (DSM-IV) [21] . Patients with dementia were further subjected to brain computed tomography (CT) or magnetic resonance image (MRI). We made a diagnosis of AD according to the criteria of National Institute of Neurological and Communicative Diseases and Stroke/Alzheimer's Disease and Related Disorders Association (NINCDS-ADRDA) [22] . Diagnosis of vascular dementia was based on the criteria of National Institute of Neurological Disorders and Stroke/Association Internationale pour la Recherche et l'Enseignement en Neurosciences (NINDS-AIREN) [10] .
(6) Global assessment of vascular risk in the patients with AD: Besides individual vascular risk factors, the HIS was used to generate a global assessment of vascular diseases in the AD patients following a validated method in which HIS was used to dichotomize the patients with AD into two groups (without vascular risk = 0, with vascular risk = score 1 to 4) [23] .
Follow-up
During the baseline screening, 432 out of 7831 screened were diagnosed as AD without CVD, 7 of which were unable to comply with the study assessment and 10 declined to take part in the present study, thus leaving 415 cases enrolled into the present study at baseline. Subjects were followed up by trained neurologists or psychiatrists annually for 5 years from July 1, 2004 to June 30, 2009. On each follow-up, the cognitive function (MMSE) and daily activity function (ADL) were assessed. Cranial CT or MRI measures were performed when neurological signs indicating new brain lesion occurred during the follow-up. Incidence of vascular diseases was collected based on the medical record or evaluation by the neurologists.
Statistical analysis
The relationship between vascular risk, individual vascular risk factors, and deterioration of AD was analyzed by univariate and multivariate analysis. First, the differences in the rate of cognitive and functional decline during the five years were compared to vascular risk or individual vascular risk factors in the univariate analysis, including t test for association in independent normally distributed continuous data, Chi square test for categorical data, and the Mann-Whitney U test for associations between ordinal and categorical variables if the data were not normally distributed.
To take into account the repeated MMSE and ADL measures during the follow-up, cognitive and functional decline in terms of MMSE and ADL changes were further analyzed to check for the interactions between time and vascular risk or individual vascular risk factors with two mixed random effects regression models, in which a significant time effect indicates a change in MMSE or ADL score over time, and a significant interaction between vascular risk or individual vascular risk factors and time indicates a differential change in MMSE and ADL according to vascular risk or individual vascular risk factors. In Model one, the association between vascular risk or each vascular variable with cognitive and functional decline was assessed. Taking hypertension as an example, the dependent variables were changes for cognitive or functional scores, and predictor variables were hypertension, time (years), and a hypertension-time interaction. Confounding factors, including age, gender, educational level, occupation, baseline MMSE and ADL scores, and use of acetylcholinesterase inhibitor (AChEI) at baseline and follow-up, were simultaneously introduced into the model. A significant hypertension effect would suggest a hypertension-associated difference in cognition or function, and a significant interaction term would sug- gest differential hypertension associated rates of cognitive or functional changes over time. In Model two, whether vascular risk or any vascular factor was independently associated with cognitive and functional decline was determined by simultaneously including all variables associated with cognitive and functional decline in Model one with adjustment for age, gender, educational level, occupation, baseline MMSE and ADL scores, and use of AChEI at baseline and follow-up. The statistical analyses were performed using SPSS 15.0 for Windows.
RESULTS
415 AD patients without CVD were enrolled at baseline. Five years later, 324 (78.1%) people completed the follow-up, while 43 (10.4%) died, 39 (9.4%) declined, and 9 (2.2%) moved away during the follow-up (Fig. 1) .
The demographic and vascular risk factor characteristics at baseline of the AD patients who completed the follow-up and those who did not complete the follow-up were shown in Table 1 . For participants who completed the follow-up, the average age was 72.9 ± 4.14 years, and most of them were female (70.4%), had lower education (67.3%), and blue-collar occupations (69.4%). The mean baseline MMSE score was 15.5 ± 1.59 and ADL score was 46.8 ± 5.22. 52.8% of the participants were APOE4 carriers. The baseline frequency of hypertension was 35.5%, diabetes 21.3%, hypercholesterolemia 17.3%, overweight 15.1%, myocardial infarction 3.4%, atrial fibrillation 6.8%, TIA 12.3%, current smoking 17.6%, and daily drinking 13.3%. 57.7% of participants were judged to have vascular risk based on HIS score based algorithms validated previously [23] . Compared to the subjects who completed the follow-up, those who did not complete the follow-up had higher frequency of diabetes (p = 0.021), obesity (p = 0.013), and myocardial infarction (p = 0.011), but did not differ in other variables.
During the follow-up, the patients who had vascular risk factors such as hypertension, diabetes, and hypercholesterolemia were on medication and special diet, and 297 patients (91.7%) were on AChEIs. 13 (3.1%) reported new occurrence of TIA and 41 (9.9%) reported new occurrence of CVA during the follow-up, among them 32 were cerebral infarction and 9 were cerebral hemorrhage. No occurrence of other vascular risk factors was detected during the follow-up. After five-year follow-up, the overall change in MMSE scores was −7.980 ± 2.681 and 13.590 ± 3.422 for ADL scores. Table 2 shows the univariate analysis for the association between vascular risk, individual vascular risk factors, cerebrovascular events (TIA and CVA), APOE4, and decline rate of cognitive and functional impairment in terms of MMSE and ADL differences respectively during follow-up. Globally, subjects with vascular risk had higher rates of cognitive and functional deterioration than subjects without. Among these factors, hypertension, diabetes, TIA, and CVA during follow-up were associated with more rapid decline in cognition and function in AD patients.
Univariate analysis for the association between vascular risk and rate of cognitive and functional decline in AD
Mixed random effects regression analysis for the association between vascular risk, individual vascular risk factors, and the progression of AD
Cognitive and functional decline over time. In the adjusted mixed model, cognition and function declined over time (MMSE: β = −1.467, P < 0.001; ADL: β = −2.818, P < 0.001). A quadratic term for time, added to the model to test whether cognitive change was nonlinear, was non-significant.
Results of Model one for vascular risk and each predictor are given in Table 3 . Globally, vascular risk was associated with faster decline in cognition (β = −1.059 ± 0.109, p < 0.001) and function (β = −1.954 ± 0.099, p < 0.001). Of the vascular risk variables, hypertension, diabetes, TIA, and CVA during the followup were associated with faster decline in cognition and function.
We further examined the association between disease progression and vascular risk factors by multivariate analysis in the mixed model (Model two) that simultaneously included vascular risk and individual vascular risk which were significant in Model one including hypertension, diabetes, TIA, and CVA during the followup. Their interaction with time remain significant for MMSE and ADL (Table 4) .
DISCUSSION
The present study aimed to investigate whether AD patients with vascular risk may have significant decline in terms of cognition and function. We found that globally the AD patients with vascular risk had higher rate of cognitive and functional deterioration during the five year follow-up. Mixed random effects regression analysis demonstrated that hypertension, diabetes mellitus, TIA, and CVA occurring during the follow-up were independently associated with the progression of AD.
In recent years, it has been proposed that AD may be a kind of cognitive impairment derived from vascular pathological changes, and the association between vascular risk factors and AD has been studied [1] [2] [3] 24, 25] . There has been evidence demonstrating that vascular risk factors increase the occurrence risk of AD [3] [4] [5] [6] [7] . The vascular risk factors have impact on AD occurrence by destroying or reducing cerebral perfusion and thus damaging neurons [1, 25] . Recent evidence suggests that vascular risk factors may influence the progression of AD. A prospective study on the association between hypercholesteremia and the progression of AD found that hypercholesteremia aggravated cognitive deterioration of AD patients and that statins were effective in delaying the progression of AD [26] . Another prospective study suggested that AD patients with hypertension had a higher risk for cognitive decline [27] . Besides the above studies focusing on a sin- gle vascular risk factor, there have been few prospective studies enrolling multiple vascular risk factors simultaneously to observe their effects on the progression of AD in recent years. Among the vascular risk factors studied, CVA [23, 28] , diabetes mellitus [28, 29] , atrial fibrillation [30] , hypertension [30] , coronary heart disease [30] , and high low-density lipoprotein (LDL) [29] were individually found to be associated with deterioration of AD. However, the results differ between the studies. The association between vascular risk factors and the progression of AD needs to be further studied. Our study is the first to study the effect of vascular risk on progression of AD in China. We conducted the five years prospective study by enrolling a large cohort of 324 patients with AD living in Chongqing, the biggest municipality in China with a large population, whose population proportion characteristics is representative of the whole country [9] . All of the patients with AD were diagnosed based on the standard diagnostic flow sheet of AD and diagnostic criteria of NINCDS-ADRDA. With comparable methodology used in other studies [23, 28, 29] , we found that vascular risk is associated with faster progression of AD in our Chinese cohort, and among the individual vascu- lar risk factors, hypertension, diabetes mellitus, TIA, and CVA during follow-up are independent predictors of faster progression of AD, which are consistent with the findings of other studies conducted in western cohorts, despite the significant differences in stroke risk profiles induced by lifestyles, dietary patterns, and other environmental factors between Chinese and Western populations [9, 31] . Two main mechanisms might be plausible to explain the effects of vascular risk factors on the faster deterioration of AD: ischemic brain lesions caused by vascular risk factors and increase in brain amyloid-β in-duced by hypoxia. CVA occurring during the followup is closely associated with greater cognitive deterioration in the present study. This is consistent with other retrospective studies by autopsy [32, 33] , which suggests that CVA contributes significantly to the clinical severity of AD. It is also possible that AD patients without CVD enrolled in the present study also had mixed dementia with silent vascular lesions [34, 35] . The accumulation of ischemic brain lesions resulted from CVA during follow-up worsened the cognition and function of the patients. In parallel, recent studies suggest that hypoperfusion and hypoxia, resulting from vascular risk factors, can also result in amyloid-β accumulation by stimulating its production or inhibiting its degradation [36] [37] [38] [39] [40] [41] . In addition, recent studies suggest that disturbances of the insulin-signaling pathway is emerging as a common feature of AD and diabetes type 2 [42] or 1 [43] . This might partly contribute to the effect of diabetes on the progression of AD observed in the present study.
Medication is an important factor which may influence the progression of AD. A recent study suggests that intervention for vascular risk factors, including hypertension, dyslipidemia, diabetes mellitus (type I or type II), tobacco smoking, and atherosclerotic disease, can slow down the progression of AD [44] . In the present study, for the ethical reason, all the patients were on the medicine during the follow-up, thus we could not study the effect of medication for vascular risk factors on the disease progression. The medication would lessen the impact of vascular risk factors on the cognitive decline. Although all the patients with vascular risk factors were recommended to take medication, it is possible that not all the patients were compliant and had the vascular risk factors under control. Despite this, we still found a significant effect on the deterioration of cognition, supporting the power of vascular risk factors on the cognitive decline in AD patients.
Recent studies have suggested that AChEI can slow the progression of AD [45] . In the present study, the small amount (8.3%) of participants who were not on AChEI relative to the majority (91.7%) of participants who were on AChEI during follow-up may preclude us to draw a conclusion.
Because of its widespread use and ease of administration, the MMSE was the only cognitive evaluation test repeated for all patients. Its validity has also been well established in the elderly Chinese people [13] . However, we acknowledge that, although MMSE is sensitive to attention, recall, and language, it does not encompass all the cognitive deficits and is particularly weak in its ability to measure executive dysfunctions which is expected in patients with vascular risk. To amend this limitation, ADL was used in parallel to reflect the executive dysfunction. Consistently, vascular risks are also associated with the deterioration in daily activities of AD patients in the present study. However, more extensive tests would be helpful to detect the changes in different cognitive domains in future studies.
It is possible that the strength of vascular risk factors on cognitive decline may vary depending on stage of the disease. In the present study, we could not estimate the duration of AD and the patients were in different stages of dementia. Estimation of disease onset is helpful to address this issue.
The prevalence of AD in persons aged 65 or over is 5.2% in our study and 4.8% in a recent study of four cities in China, suggesting that the prevalence of AD in China is comparable with that in western countries [46, 47] . Considering the rapid population aging of the Chinese population [48] , China is also facing a serious AD prevalence. Our study demonstrates that vascular risks including hypertension, diabetes mellitus, TIA, and CVA during the follow-up are associated with the faster progression of AD in a Chinese cohort. Together with other studies, we put further evidence to support the etiologic roles of vascular risk in the progression of AD. Vascular risk may lead to cognitive loss independently of AD pathology. Individuals with both of these disorders may decline more rapidly than individuals with only one. Given the fact that no strong disease-modifying prevention and treatment for AD are currently available, active intervention of vascular risk may delay the deterioration and development of AD, and thus would be a promising avenue to prevent the occurrence and hold the progression of AD [44] .
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